Table 1.
NR2F2 Sequence Alterations Identified in Individuals with AVSDs and Other Heart Structural Phenotypes
| Family | Subject | Sex | Phenotype | DNA Mutationa | Protein Changeb | Variant Type | GERP++c | De Novo or Inherited | Seen in Unrelated Control Subjectsd |
|---|---|---|---|---|---|---|---|---|---|
| 1 | I:1 | M | TOF | c.220_222dup | p.Gln75dup | in-frame duplication | – | ND | no |
| 1 | II:1 | M | cAVSD | c.220_222dup | p.Gln75dup | in-frame duplication | – | inherited from affected father | no |
| 1 | II:2 | M | AS and VSD | c.220_222dup | p.Gln75dup | in-frame duplication | – | inherited from affected father | no |
| 2 | II:1 | F | cAVSD | c.1022C>A | p.Ser341Tyr | missense | 5.15 | de novo | no |
| 3 | II:1 | M | iAVSD | c.614A>T | p.Asn205Ile | missense | 5.05 | de novo | no |
| 4 | II:1 | F | ubAVSD | c.753G>C | p.Glu251Asp | missense | 4.17 | inherited from unaffected mother | no |
| 5 | II:1 | F | cAVSD | c.1234G>T | p.Ala412Ser | missense | 5.74 | inherited from unaffected father | yes |
| 6 | II:1 | M | pAVSD | c.509A>T | p.Asp170Val | missense | 5.00 | ND | no |
| 7 | II:1 | F | HLHS | c.970+1G>A | – | splice donor | 4.06 | de novo | no |
| 8 | II:1 | M | CoA | (14;15)(q23;q26.3) | – | balanced translocation | – | de novo | no |
Abbreviations are as follows: AVSD, atrioventricular septal defect; pAVSD, partial AVSD; cAVSD, complete AVSD; ucAVSD, unbalanced complete AVSD; iAVSD, intermediate AVSD; TOF, tetralogy of Fallot; HLHS, hypoplastic left heart syndrome; AS, aortic stenosis; VSD, ventricular septal defect; CoA, coarctation of aorta; –, not applicable; ND, parent DNA was unavailable.
Position on NR2F2 cDNA RefSeq NM_021005.3.
Position on NR2F2 protein product RefSeq NP_066285.1.
GERP++ are single-nucleotide conservation scores.
Control subjects include 894 and 4,300 European samples from UK10K and NHLBI-ESP data sets, respectively.